AIM ImmunoTech Inc.
USD0.73
-0.09 (-11.46%)
CEO
Thomas K. Equels
IPO Date
1995-11-02
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
US
Open
$0.75
Prev. Close
$0.83
Day Low
$0.67
Day High
$0.79
52W Low
$0.21
52W High
$19.74
Market Cap
$0.00B
Volume
8.22M
| 25 |
| $0.00 |
| 16 Mar 2026 | CHEMEROW DAVID I. | director | C-Conversion | Acquired | 25,000 | $0.00 |
| 16 Mar 2026 | CHEMEROW DAVID I. | director | C-Conversion | Disposed | 25 | $0.00 |
| 10 Mar 2026 | Equels Thomas K | CEO & President | J-Other | Acquired | 25 | $1000.00 |
| 10 Mar 2026 | Equels Thomas K | CEO & President | J-Other | Acquired | 50,000 | $1.00 |
| 10 Mar 2026 | CHEMEROW DAVID I. | director | J-Other | Acquired | 25 | $1000.00 |
| 10 Mar 2026 | CHEMEROW DAVID I. | director | J-Other | Acquired | 50,000 | $1.00 |
| 6 Feb 2026 | CHEMEROW DAVID I. | director | A-Award | Acquired | 2,800 | $1.23 |
| 21 Jul 2025 | KELLNER TED D | director: | Disposed | 0 | $0.00 |